Over the past few years the importance of Pseudomonas aeruginosa as a human pathogen in a variety of infections has increased dramatically. Of particular significance is its increasing incidence of nosocomial infections of individuals already debilitated by other diseases, as well as in those receiving extensive radiation therapy or prolonged treatment with corticosteroids, antineoplastic drugs, or antibiotics (2, 7) . Unfortunately, little is known about the mechanism by which this organism exerts its toxic effects on the host. Although endotoxin is present in P. aeruginosa, it would appear that it does not play as important a role in the infectious processes as with other gram-negative organisms. In addition to endotoxin (14) , the organism produces a variety of extracellular substances that may conceivably play a role in the disease process (1, 3, 4, 9, 11, 12, 13, 16, 19) . However, most of these various factors have not been extensively purified prior to their in vivo studies.
Of particular interest are the proteolytic enzymes of the organism since Margaretten et al. (10) noticed a necrotizing vasculitis in infected patients. They presumed that these lesions, which are highly characteristic of Pseudomonas septicemia, were due to the production of necrotizing proteases by the organism while residing in the arterial walls of patients suffering from leukemia or burn injury. Recent studies in our laboratory with a protease exhibiting elastase activity from P. aeruginosa indicate that it exhibited both lethal and dermonecrotic properties (11) . In addition to elastase, a collagenase has been isolated from P. aeruginosa and has been recently purified several thousandfold (Bacteriol. Proc., p. 128, 1971). Consequently, the purpose of this manuscript is to extend our initial observations on the proteases of P. aeruginosa by describing the in vivo activity of a collagenase when administered to mice by a variety of routes.
MATERIALS AND METHODS
Organism. A strain of P. aeruginosa (L-1) isolated from a patient with emphysema suffering from Pseudomonas pneumonia at Detroit General Hospital was employed in this study.
Cultivation. The growth medium for routine harvesting of collagenase activity from broth media consisted of 5% peptone (Difco) and 0.25% Trypticase soy. After inoculation of 5 liters of broth in a 15-liter fermentor (New Brunswick model FS-314), the culture was grown with constant aeration for 24 hr at 37 C.
Enzyme harvest and fractionation. After the incubation interval, the supernatant fluid was separated from the cells by centrifugation with a Sorvall RC2B centrifuge at 6,100 x g for 1 hr. (19) , and the enzyme was irreversibly inactivated by ammonium sulfate, thereby indicating that the enzyme was different from that described by other workers (3, 4, 16, 19 revealed a significant reduction of duodenal collagen. Lytic lesions in the tunica muscularis indicated that the protease exhibiting collagenase activity also attacked proteins other than just collagen alone (Fig. 2) .
Intravenous route. Animals receiving the LD,0 dose of 288 enzyme units (318 gg of protein) became inactive and developed a ruffled fur and crusts around the eyes. Animals surviving the 72-hr holding period made a swift and complete recovery. With doses above the LD50 value, such as 350 units, animals showed marked pulmonary distress. Death occurred within a few minutes, and there was bleeding from the nose and mouth. Gross lesions seen subsequent to the administration of 288 enzyme units consisted of petechial hemorrhages and focal necroses in the lungs plus abdominal hemorrhage within 24 to 72 hr. In addition, the lumen of the small intestine was filled with partially digested blood. With doses above the LD50 value (300-325 units), severe hemorrhage and necrosis of the lungs could be obtained within 3 hr, whereas a dose of 250 units yielded milder pulmonary damage. Histologically, with the LD50 dose, striking lung hemorrhage, necrosis, and capillary hyperemia were noted ( Fig. 1) , along with some hepatic congestion. In the lamina propria and tunica muscularis of the small intestine, hemorrhage was observed that frequently extended into the serosa. By means of trichrome staining, collagen appeared to be broken down in the submucosa of the duodenum. Typical duodenal damage due to the collagenase can be seen in Fig. 3 oped and became almost immediately necrotic when 200 to 300 units of enzyme were administered. The skin was eventually lost from the FIG. 4. Severe hemorrhage and necrosis can be tail at the site of inoculation (Fig. 4) . Doses as seen in the tail of a mouse which had received a small low as 45 enzyme units (50 ug of protein) could amount of collagenase subcutaneously. Comparison of these in vivo results with those of the previously purified elastase on an enzyme units basis is difficult since different units are involved; however, on a protein basis, it would appear that the elastase may be slightly more toxic than the collagenase by the intranasal and intraperitoneal routes, but not by the intravenous route. Of particular interest is that neither enzyme exhibited any lethality or pathological manifestations when administered in an enzymatically inactive form. Consequently, the in vivo responses of the mice appears to be directly dependent upon enzymatic activity since there appears to be no inherent toxicity associated with the enzymatically inactivated enzyme protein as such. In addition, it would appear that the toxic effect of the collagenase is predominantly due to damage of the small blood vessels rather than to the major destruction of collagen and other susceptible tissue proteins. These results are consistent with the fact that P. aeruginosa has an affinity for small arteries and can reside in the arterial wall.
In the past, a collagenolytic factor from P. aeruginosa has been implicated in the destruction of corneal tissue as well as exhibiting other manifestations (3, 4, 5, 13). Currently, the pathological manifestations of collagenase administered to mice is of pertinent clinical importance since there have been reports of alveolar hemorrhage frequently observed in patients with P. aeruginosa septicemia (18) . In addition, in cases of cystic fibrosis of the pancreas, it is not uncommon to see the development of a predisposition to pulmonary complications due to P. aeruginosa and other organisms (7) . Therefore, it is of special interest that both the intravenous and intranasal routes resulted in varying degrees of lung damage and hemorrhage as one of the major pathological changes. However, the observed LD50 values for the two routes were substantially different, and the real difference may be even greater since the instillation of a defined dose of collagenase by the intranasal route is much more difficult to control. Consequently, some of the instilled enzyme could have been swallowed or even sneezed out thereby making the actual enzyme dosage in the lungs considerably less than the actual dosage employed. Since circumscribed fields of hemorrhage and necrosis were histologically observed along with thombi in many vessels of the lungs, it is logical to assume that these fields are infarcts of thromboembolic origin. As for the intravenous route, the lower lethality of the collagenase may be due to the dilution of the enzyme in blood and tissue spaces, inhibitory salt concentrations, the nonspecific binding of the enzyme to potential substrates that may not be involved in a visible proteolytic reaction, or the presence of nonspecific serum-inhibitory factors that may inactivate the enzyme before it can act. However, despite all these possibilities it is quite clear that extensive tissue damage still ensued and the destruction of tissues containing collagen such as the submucosa of the duodenum suggests that this may be one of the target organs of the enzyme. Similar histological results with intraperitoneal injections were obtained; however, these may not be quite as significant as the intravenous studies since the administration of enzyme by this route allows it to act directly on the intestinal tract. Consequently, pathological changes obtained by this route are most likely due to a more intimate proteolytic action on the intraabdominal organs of the mice.
Although the subcutaneous route was least effective in terms of producing death, it was also of potential significance since the enzyme produced a rapid destruction of the skin and subcutaneous tissue at the site of injection. Such lesions were macroscopically similar to the P. aeruginosa-induced skin lesions observed in human infections termed "ecthyma gangrenosum" (6) . Since similar results were obtained with the P. aeruginosa elastase (11) , it now appears that from a clinical point of view any skin damage noted with P. aeruginosa is probably due in part to the elaboration of one or more proteolytic factors by the organism.
